These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

591 related items for PubMed ID: 28333757

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Effect of Body Weight on Hemodynamic Response in Patients Receiving Fixed-Dose Vasopressin for Septic Shock.
    Hodge EK, Hughes DW, Attridge RL.
    Ann Pharmacother; 2016 Oct; 50(10):816-23. PubMed ID: 27340145
    [Abstract] [Full Text] [Related]

  • 45. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial.
    Lauzier F, Lévy B, Lamarre P, Lesur O.
    Intensive Care Med; 2006 Nov; 32(11):1782-9. PubMed ID: 17019548
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Beneficial effects of short-term vasopressin infusion during severe septic shock.
    Patel BM, Chittock DR, Russell JA, Walley KR.
    Anesthesiology; 2002 Mar; 96(3):576-82. PubMed ID: 11873030
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials.
    Russell JA, Lee T, Singer J, De Backer D, Annane D.
    J Crit Care; 2018 Oct; 47():333-337. PubMed ID: 29958734
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials.
    Nagendran M, Russell JA, Walley KR, Brett SJ, Perkins GD, Hajjar L, Mason AJ, Ashby D, Gordon AC.
    Intensive Care Med; 2019 Jun; 45(6):844-855. PubMed ID: 31062052
    [Abstract] [Full Text] [Related]

  • 55. Vasopressin vs noradrenaline: Have we found the perfect recipe to improve outcome in septic shock?
    Chidambaram S, Goh EL, Rey VG, Khan MA.
    J Crit Care; 2019 Feb; 49():99-104. PubMed ID: 30415181
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Effect of early vasopressin combined with norepinephrine on short-term mortality in septic shock: A retrospective study based on the MIMIC-IV database.
    He D, Zhang L, Hu H, Gu WJ, Lu X, Qiu M, Li C, Yin H, Lyu J.
    Am J Emerg Med; 2023 Jul; 69():188-194. PubMed ID: 37167890
    [Abstract] [Full Text] [Related]

  • 60. Optimizing Vasopressin Use and Initiation Timing in Septic Shock: A Narrative Review.
    Sacha GL, Bauer SR.
    Chest; 2023 Nov; 164(5):1216-1227. PubMed ID: 37479058
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.